Laval, Canada-based Valeant Pharmaceuticals CEO Joe Papa made a bet on his salary as half of his compensation package relies on Valeant’s stock performance.
Valeant Pharmaceuticals’ former CEO Michael Pearson is suing the company for 3 million in shares that the company allegedly withheld from his exit package.
Irving, Texas-based Miraca Life Sciences expanded its InformTx therapeutic drug monitoring program to include Simponi and patient-developed antibodies to Simponi.
More articles on gastroenterology:
6 facts on gastroenterologist salary in 2017
Death rates decreasing for colorectal cancer overall; Liver cancer on the rise
Miraca Life Sciences expands therapeutic drug monitoring service includes Simponi: 4 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.